There are trillions of bacteria that live in your colon. Most of them are harmless and many are actually helpful, supporting digestion and keeping your immune system strong. C. diff is one type of ...

There are about half a million C. diff infections every year in the United States. About 30,000 people die from them annually. But if you’ve had C. diff, you’re more likely to get it again. About 1 in ...

Prompt treatment with fecal transplant can improve survival among critically ill C. difficile patients 14 of 18 patients with life-threatening C. diff survived after a fecal transplant Antibiotics ...

DEAR DR. ROACH: I read your recent column about a person who was refusing antibiotics due to a fear of a Clostridioides difficile (C. diff) recurrence. I am interested in your thoughts regarding ...

Her son had been sick for four months when Blanca Morales started asking about a transplant. It had started with a case of strep throat from Mundo’s first-grade class — routine enough, treatable with ...

An experimental antibiotic called EVG7 has shown promise against gram-positive bacterium Clostridioides difficile, the leading cause of healthcare and antibiotic-associated diarrhea in the US and ...

Dear Dr. Roach: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...

Nashville, Tenn.-based Vanderbilt Health researchers have developed a promising novel vaccine to treat Clostridioides difficile infections. Previous vaccine strategies targeted the bacterium’s primary ...

A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...

DEAR DR. ROACH: I am a 76-year-old male who is in relatively good health. For the past six months, I have been experiencing diarrhea on and off. I initially spoke to my general physician, and he ...

ATLANTA -- Mortality rates from Clostridioides difficile-related infections have fallen steadily since 2016, but the condition continues to take an uneven lethal toll based on sex, demographics, and ...